Cancer Trials are Changing. That Could Mean Faster Access to Better Drugs

The Washington Post examines a new model of cancer research, which focuses on precision medicine. Instead of finding drugs to treat cancers in specific organs, new trials seek to group patients together based on similar genetic mutations, regardless of cancer location.

Link to this article